Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
  • Careers & studies
        • Careers & Studies

          Take the next step in your career with Centenary, Australia’s foremost clinically integrated medical research institute

          Learn more

        • Career opportunities
        • Life at Centenary
        • Post-Doctorate Research
        • PhD
        • Masters
        • Honours
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Contact
  • Donate
    Centenary Institute > News > New study to investigate lung treatment for COVID-19

New study to investigate lung treatment for COVID-19

Date time 13 October, 2021
News Type News type Media release
Dr Matt Johansen from the Centenary UTS Centre for Inflammation is the successful recipient of the Kenyon Foundation Inflammation Award for 2021.

Dr Matt Johansen from the Centenary UTS Centre for Inflammation is the successful recipient of the Kenyon Foundation Inflammation Award for 2021. The Award, valued at $20,000, will support Dr Johansen’s study into the development of a potential new treatment for COVID-19 aimed at reducing excessive inflammation in the lungs.

“There’s an urgent need to identify effective therapies that can be used to treat COVID-19 and significantly reduce mortality. Excessive lung inflammation is often the cause of severe disease and death in COVID-19,” said Dr Johansen.

In his study, Dr Johansen will be targeting the NLRP3 inflammasome, a master regulator of inflammation which drives a cascade of downstream inflammatory processes in severely affected COVID-19 patients. A known inhibitor of the NLRP3 inflammasome–a molecule known as MCC950–will be investigated for its efficacy as a potential COVID-19 treatment.

“MCC950 has already been shown to mitigate lung inflammation associated with respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD),” said Dr Johansen.

“It’s also been shown to be highly effective in alleviating virally-driven inflammation in influenza, suggesting it may also be an effective treatment for COVID-19.”

Dr Johansen’s study will be carried out at the Centenary Institute’s high-containment PC3 facility, of which there are only four in Australia that are properly equipped to complete this form of specialised SARS-CoV-2 medical research.

“I am incredibly humbled to have been selected for this Award which will financially assist our efforts to identify the most effective therapies for COVID-19,” said Dr Johansen.

“As governmental funding becomes increasingly difficult to acquire, philanthropic support from organisations such as the Kenyon Foundation are a significant boost that can promote fundamental scientific research that benefits us all.”

David Kenyon, Trustee of the Kenyon Foundation said, “We’re thrilled to be able to support Dr Johansen’s research that could form the basis for new therapies for the treatment of COVID-19 that has the potential to change lives.”

Themes

  • Inflammation

    Inflammation

People

  • Dr Matt Johansen

    Node leader for Bacterial and Viral Immunopathogenesis/Host-Pathogen Interactions

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Download

Recent Stories

  • Inflammation presentation awarded

    Dr Joyce Chiu from the ACRF Centenary Cancer Research Centre has won an Oral Communication Award for her talk given at the 15th World Congress on Inflammation, held in Rome, June 2022.
    News Type: Research News
    Date 01 Jul 2022
  • Meet Dr Annalicia Vaughan

    A medical researcher at the Centenary UTS Centre for Inflammation, Dr Annalicia Vaughan specialises in the gut-lung axis and its role in lung and respiratory diseases.
    News Type: Profiles
    Date 28 Jun 2022
    Dr Vaughan
  • The Centenary Institute is excited to join the Sydney Biomedical Accelerator (SBA) as primary medical research partner

    The Centenary Institute welcomes the NSW Government’s commitment to fund a new biomedical complex in Camperdown. The Chair of the Centenary Institute Board, Joseph Carrozzi AM, and its Executive Director, Professor Mathew Vadas AO, are thrilled that a biomedical complex, the Sydney Biomedical Accelerator (SBA), will now be a reality.
    News Type: Media release
    Date 17 Jun 2022
  • Innovation Week –  Getting to the heart of sudden death

    Professor Chis Semsarian AM, Head of the Agnes Ginges Centre for Molecular Cardiology at the Centenary Institute and Cardiologist at the Royal Prince Alfred Hospital, has given a headline talk on the genetic basis of cardiovascular disease as a part of Sydney Local Health District’s 'Innovation Week' event.
    News Type: Research News
    Date 03 Jun 2022

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Laboratories
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram